Avid Bioservices, Inc. (CDMO)
NASDAQ: CDMO · IEX Real-Time Price · USD
9.02
-0.10 (-1.10%)
May 20, 2024, 12:08 PM EDT - Market open
Avid Bioservices Revenue
Avid Bioservices had revenue of $136.74M in the twelve months ending January 31, 2024, down -2.81% year-over-year. Revenue in the quarter ending January 31, 2024 was $33.82M, a -11.06% decrease year-over-year. In the fiscal year ending April 30, 2023, Avid Bioservices had annual revenue of $149.27M with 24.81% growth.
Revenue (ttm)
$136.74M
Revenue Growth
-2.81%
P/S Ratio
4.23
Revenue / Employee
$374,616
Employees
365
Market Cap
573.22M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2023 | 149.27M | 29.67M | 24.81% |
| Apr 30, 2022 | 119.60M | 23.73M | 24.75% |
| Apr 30, 2021 | 95.87M | 36.17M | 60.58% |
| Apr 30, 2020 | 59.70M | 6.10M | 11.38% |
| Apr 30, 2019 | 53.60M | -18.00K | -0.03% |
| Apr 30, 2018 | 53.62M | -4.01M | -6.96% |
| Apr 30, 2017 | 57.63M | 13.27M | 29.92% |
| Apr 30, 2016 | 44.36M | 17.58M | 65.63% |
| Apr 30, 2015 | 26.78M | 4.38M | 19.55% |
| Apr 30, 2014 | 22.40M | 718.00K | 3.31% |
| Apr 30, 2013 | 21.68M | 6.45M | 42.34% |
| Apr 30, 2012 | 15.23M | 1.74M | 12.90% |
| Apr 30, 2011 | 13.49M | -14.45M | -51.72% |
| Apr 30, 2010 | 27.94M | 9.79M | 53.95% |
| Apr 30, 2009 | 18.15M | 12.06M | 197.90% |
| Apr 30, 2008 | 6.09M | 2.39M | 64.32% |
| Apr 30, 2007 | 3.71M | 515.00K | 16.13% |
| Apr 30, 2006 | 3.19M | -1.77M | -35.61% |
| Apr 30, 2005 | 4.96M | 1.65M | 49.64% |
| Apr 30, 2004 | 3.31M | -607.00K | -15.48% |
| Apr 30, 2003 | 3.92M | 155.00K | 4.12% |
| Apr 30, 2002 | 3.77M | 2.79M | 284.68% |
| Apr 30, 2001 | 979.00K | 929.00K | 1,858.00% |
| Apr 30, 2000 | 50.00K | - | - |
| Apr 30, 1999 | 0 | - | - |
| Apr 30, 1998 | 0 | - | - |
| Apr 30, 1997 | 0 | - | - |
| Apr 30, 1996 | 3.14M | 3.14M | 42,429.06% |
| Apr 30, 1995 | 7.39K | -61.98K | -89.34% |
| Apr 30, 1994 | 69.37K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PetIQ | 1.12B |
| Accolade | 414.29M |
| GeneDx Holdings | 221.85M |
| Taysha Gene Therapies | 14.16M |
| Altimmune | 410.00K |
| Allogene Therapeutics | 65.00K |
CDMO News
- 3 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO - PRNewsWire
- 12 days ago - Avid Bioservices to Participate at Upcoming Investor Conferences - GlobeNewsWire
- 25 days ago - Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 - GlobeNewsWire
- 2 months ago - Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q - GlobeNewsWire
- 2 months ago - Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors - Business Wire
- 2 months ago - Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - Business Wire
- 2 months ago - INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors - Business Wire
- 2 months ago - The Law Offices of Frank R. Cruz Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors - Business Wire